Blog icon

Leading healthier lives for longer

A researcher at a computer using software to analyse biomarkers

With the potential to ease the burden of disease in Australia, the evolving diagnostics industry is facilitating a shift from managing chronic diseases as they arise to detecting them well before they've had a chance to take hold.

We're contributing to this rapidly expanding industry by developing solutions to detect chronic diseases like cancer, Alzheimer's disease and metabolic diseases earlier and more accurately than ever before.

This can help us to intervene at the earliest moment, develop more effective treatment, and even prevent certain diseases from developing in the first place – helping Australians and the rest of the world to lead healthier lives for longer.

Developing advanced diagnostics

With strong clinical collaborations and our Future Science Platforms, our diagnostics research team delivers across the following areas:

  • developing robust biomarkers to more accurately detect diseases earlier
  • creating new models of human disease for drug and bioactive testing
  • developing non-invasive saliva and oral swab tests.

Our partners in diagnostics

We've partnered with:

  • Rhythm Biosciences
    • to develop and commercialise a highly sensitive blood test for the early detection of colorectal cancer, ColoSTAT™.
  • Clinical Genomics and Flinders University
    • to develop a blood test for the recurrence of colorectal cancer, Colvera™, which was successfully launched in the US market in 2017.
  • Biosensis
    • to develop new markers of Alzheimer's disease in saliva.

Leading healthier lives for longer

Point-of-care testing provides portable, non-invasive platforms for accurate and faster analysis, detection and monitoring of disease markers.

With the potential to ease the burden of disease in Australia, the evolving diagnostics industry is facilitating a shift from managing chronic diseases as they arise to detecting them well before they've had a chance to take hold.

We're contributing to this rapidly expanding industry by developing solutions to detect chronic diseases like cancer, Alzheimer's disease and metabolic diseases earlier and more accurately than ever before.

This can help us to intervene at the earliest moment, develop more effective treatment, and even prevent certain diseases from developing in the first place – helping Australians and the rest of the world to lead healthier lives for longer.

Developing advanced diagnostics

With strong clinical collaborations and our Future Science Platforms, our diagnostics research team delivers across the following areas:

  • developing robust biomarkers to more accurately detect diseases earlier
  • creating new models of human disease for drug and bioactive testing
  • developing non-invasive saliva and oral swab tests.

Our partners in diagnostics

We've partnered with:

  • Rhythm Biosciences
    • to develop and commercialise a highly sensitive blood test for the early detection of colorectal cancer, ColoSTAT™.
  • Clinical Genomics and Flinders University
    • to develop a blood test for the recurrence of colorectal cancer, Colvera™, which was successfully launched in the US market in 2017.
  • Biosensis
    • to develop new markers of Alzheimer's disease in saliva.

Do business with us to help your organisation thrive

We partner with small and large companies, government and industry in Australia and around the world.

Contact us now to start doing business

Contact us

Find out how we can help you and your business. Get in touch using the form below and our experts will get in contact soon!

CSIRO will handle your personal information in accordance with the Privacy Act 1988 (Cth) and our Privacy Policy.


First name must be filled in

Surname must be filled in

I am representing *

Please choose an option

Please provide a subject for the enquriy

0 / 100

We'll need to know what you want to contact us about so we can give you an answer

0 / 1900

You shouldn't be able to see this field. Please try again and leave the field blank.